Dr. ChatGPT Will See You Now
Patients and doctors are turning to AI for diagnoses and treatment recommendations, often with stellar results, but problems arise when experts and algorithms disagree.
Read MorePatients and doctors are turning to AI for diagnoses and treatment recommendations, often with stellar results, but problems arise when experts and algorithms disagree.
Read MoreScientists were able to create a bespoke treatment for KJ Muldoon’s rare genetic disorder within six months. It could be a blueprint for potentially life-saving, gene-editing Crispr therapies.
Read MoreAs the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 medication injected daily instead of weekly.
Read MoreAs the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 medication injected daily instead of weekly.
Read MoreWith the active ingredients in drugs like Ozempic and Zepbound no longer in shortage, access to medicine for millions who had come to rely on compounded versions is increasingly uncertain.
Read MoreCBP’s acting commissioner has rescinded four Biden-era policies that aimed to protect vulnerable people in the agency’s custody, including mothers, infants, and the elderly.
Read MoreWith measles on the rise, this episode of Uncanny Valley looks at RFK Jr.’s role in the revival of the once-eliminated deadly illness.
Read MoreWith measles on the rise, this episode of Uncanny Valley looks at RFK Jr.’s role in the revival of the once-eliminated deadly illness.
Read MoreNIAID’s Integrated Research Facility is one of the few federal facilities charged with studying Ebola. Tuesday afternoon, all of its work was put on indefinite pause by Robert F. Kennedy Jr.’s department.
Read MoreThe border state of Chihuahua has recorded 713 confirmed cases, with its outbreak linked to the ongoing cluster of cases north of the border in Texas.
Read More